Bioimpact Capital LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Bioimpact Capital LLC
CRD #309865
SEC #801-119133
CIK #0001796461, 0001687078, 0000168707
AUM
Employees 50 (62% Investors, 0% Brokers)
Phone617-425-9200
Address399 Boylston Street
Boston, MA 02116
Source [IAPD] [EDGAR] [Website] [Twitter] [LinkedIn]
Total AUM ($B)
3.02.41.81.20.60.02009201420192025
Sector Form 13F Holdings Value ($M)
DBV Technologies Sa 108.9
Cullinan Oncology Inc 108.7
Liquidia Corp 53.0
Alumis Inc 52.6
Edgewise Therapeutics Inc 52.3
Revolution Medicines Inc 49.3
Agios Pharmaceuticals Inc 44.2
Corcept Therapeutics Inc 39.7
Trevi Therapeutics Inc 39.4
Magenta Therapeutics Inc 35.6
View All
Holdings by Sector ($M)
1300104078052026002019202120242027
AUM Breakdown Accounts AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 9 2.0
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 9 2.0
By Discretionary
Discretionary 9 2.0
Non-Discretionary 0 0.0
Total 9 2.0
By Non-United States Persons
Non-United States Persons 1.9
United States Persons 0.1
Total 9 2.0
EDGAR Form CIK 2011 - 2026
13F-HR [0001687078]
3 [0001687078]
4 [0001687078]
SC 13D [0001687078]
SC 13G [0001687078]
13F-HR [0001796461]
SC 13G [0001796461]
Form 13D/13G Filer Form 13D/13G Subject Filed
MPM Bioimpact LLC Forte Biosciences Inc [2026-05-15]
MPM Bioimpact LLC DBV Technologies Sa [2026-02-17]
MPM Bioimpact LLC Climb Bio Inc [2026-02-17]
MPM Bioimpact LLC Compass Therapeutics Inc [2025-02-14]
MPM Bioimpact LLC Context Therapeutics Inc [2025-01-08]
Bioimpact Capital LLC Reunion Neuroscience Inc [2023-06-12]
Burrage Capital Management LLC Protalix Biotherapeutics Inc [2021-02-12]
Burrage Capital Management LLC Iveric Bio Inc [2019-12-12]
Firm Profile (Form ADV)
ServesInstitutional
Fund TypesHedge Fund
Form 3/4/5 Subject 2011 - 2026
Oncology Impact Fund Cayman Management LP
MPM Oncology Innovations Fund LP
Werewolf Therapeutics Inc
MPM BioImpact LLC
Gadicke Ansbert
UBS Oncology Impact Fund LP
MPM Asset Management LLC
MPM Oncology Innovations Fund GP LLC
iTeos Therapeutics Inc
TCR2 Therapeutics Inc
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Werewolf Therapeutics Inc HOWL
Common Stock
2025-12-04 Sell 83,230 $0.97 80,733
Werewolf Therapeutics Inc HOWL
Common Stock
2025-12-03 Sell 57,225 $0.87 49,786
Werewolf Therapeutics Inc HOWL
Common Stock
2025-12-02 Sell 59,277 $0.89 52,757
Werewolf Therapeutics Inc HOWL
Common Stock
2025-12-01 Sell 60,917 $0.94 57,262
Werewolf Therapeutics Inc HOWL
Common Stock
2025-11-28 Sell 20,277 $0.99 20,074
Werewolf Therapeutics Inc HOWL
Common Stock
2025-11-26 Sell 60,733 $0.98 59,518
Werewolf Therapeutics Inc HOWL
Common Stock
2025-11-25 Sell 42,533 $0.92 39,130
Werewolf Therapeutics Inc HOWL
Common Stock
2025-11-24 Sell 88,802 $0.98 87,026
Werewolf Therapeutics Inc HOWL
Common Stock
2025-11-21 Sell 64,331 $0.83 53,395
Werewolf Therapeutics Inc HOWL
Common Stock
2025-11-20 Sell 41,152 $0.89 36,625
Werewolf Therapeutics Inc HOWL
Common Stock
2025-11-19 Sell 66,324 $0.94 62,345
Werewolf Therapeutics Inc HOWL
Common Stock
2025-11-18 Sell 52,627 $0.93 48,943
Werewolf Therapeutics Inc HOWL
Common Stock
2025-11-17 Sell 57,061 $0.95 54,208
Werewolf Therapeutics Inc HOWL
Common Stock
2025-11-14 Sell 61,640 $0.93 57,325
Werewolf Therapeutics Inc HOWL
Common Stock
2025-11-13 Sell 90,951 $0.98 89,132
Werewolf Therapeutics Inc HOWL
Common Stock
2025-11-12 Sell 40,669 $1.09 44,329
Werewolf Therapeutics Inc HOWL
Common Stock
2025-11-11 Sell 55,810 $1.14 63,623
Werewolf Therapeutics Inc HOWL
Common Stock
2025-11-10 Sell 48,570 $1.18 57,313
Werewolf Therapeutics Inc HOWL
Common Stock
2025-11-07 Sell 68,480 $1.11 76,013
Werewolf Therapeutics Inc HOWL
Common Stock
2025-11-06 Sell 54,452 $1.21 65,887
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com